Have a personal or library account? Click to login
Pericardial Patch as a Palliative Treatment in Three Dogs Affected by Unresectable Cardiac Tumor Cover

Pericardial Patch as a Palliative Treatment in Three Dogs Affected by Unresectable Cardiac Tumor

Open Access
|Dec 2019

Abstract

This report is aimed at describing a pericardial patch for unresectable cardiac tumors as a palliative technique to prevent pleural effusion.

Each dog underwent the same diagnostic protocol including a cardiological assessment, hematology and biochemistry profile, urinary test, abdominal and heart ultrasonography and chest radiographs. Computed tomography was always performed in order to exclude any potential metastatic lesions. All dogs underwent open pericardiectomy: the pericardium was opened and transposed on the mass according to its shape. Biopsy of the mass was always performed. Histopathological evaluation of the masses described two HAS and one chemodectoma. Chemotherapy protocol includes doxorubicin that was weekly administered. Dogs with HSA survived 65 and 85 days respectively without pleural effusion, while the dog with chemodectoma died after six months for reasons unrelated to the tumor.

No evidence of pleural effusion was observed during the heart recheck, monthly performed.

Pericardial patch is a potential choice as a palliative treatment for unresectable cardiac tumors. No pleural effusion was seen in three dogs affected by unresectable cardiac tumors.

DOI: https://doi.org/10.2478/acve-2019-0040 | Journal eISSN: 1820-7448 | Journal ISSN: 0567-8315
Language: English
Page range: 461 - 468
Submitted on: Jul 1, 2019
|
Accepted on: Nov 19, 2019
|
Published on: Dec 21, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2019 Francesco Collivignarelli, Massimo Vignoli, Francesca Del Signore, Francesco Simeoni, Roberto Tamburro, published by University of Belgrade, Faculty of Veterinary Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.